FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029933 [Registered on: 18/12/2020] Trial Registered Prospectively
Last Modified On: 18/12/2020
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   To compare effect of erector spinae block and pecs block on recovery and pain after modified radical mastectomy 
Scientific Title of Study   Effect of erector spinae block and pecs block on quality of recovery and analgesia after modified radical mastectomy: a randomised control double blind study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
none  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Md Hammad Mohsin 
Designation  JUNIOR RESIDENT 
Affiliation  Department of Anaesthesiology KGMU Lucknow 
Address  Department of Anaesthesiology King Georges Medical University
Chowk Shahmina Road, Lucknow
Lucknow
UTTAR PRADESH
226003
India 
Phone  6205417584  
Fax    
Email  heshamkhan6@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Reetu Verma 
Designation  Additional Professor 
Affiliation  King Georges Medical University Lucknow 
Address  Department of Anaesthesiology King Georges Medical University
Chowk Shahmina Road, Lucknow
Lucknow
UTTAR PRADESH
226003
India 
Phone  9473641975  
Fax    
Email  reetuverma1998@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Reetu Verma 
Designation  Additional Professor 
Affiliation  King Georges Medical University Lucknow 
Address  Department of Anaesthesiology King Georges Medical University
Chowk Shahmina Road, Lucknow

UTTAR PRADESH
226003
India 
Phone  9473641975  
Fax    
Email  reetuverma1998@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology King Georges Medical University Lucknow  
 
Primary Sponsor  
Name  King Georges Medical University 
Address  KGMU Chowk Shahmina Road Lucknow  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Department of Anaesthesiology  King Georges Medical University Shahmina Road Lucknow  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Reetu Verma  King Georges Medical University  Department of Anaesthesiology Chowk Shahmina Road Lucknow
Lucknow
UTTAR PRADESH 
9473641975

reetuverma1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N649||Disorder of breast, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  pain monitoring  Hemodynamic variables pulse rate , blood pressure (NIBP),SpO2 will be recorded before surgery and thereafter at every 15 minutes. • VAS Score will be observed before surgery and then immediately after extubation and then at 1hr,2hr,4hr,6hr,12hr,24hrs • Total consumption of rescue analgesia in 1st 24 hrs  
Comparator Agent  Quality of Life   Quality of Recovery( QoR-40) score at 24hrs 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Female 
Details  Age 18-70 years
ASA grade 1 and 2
Patient giving written informed consent
Female
unilateral modified radical mastectomy for breast cancer
 
 
ExclusionCriteria 
Details  Endocrine disorders (including I and II type of Diabetes mellitus),
Allergies to local anesthetics
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
• Hemodynamic variables pulse rate , blood pressure (NIBP),SpO2 will be recorded before surgery and thereafter at every 15 minutes.
• VAS Score will be observed before surgery and then immediately after extubation and then at 1hr,2hr,4hr,6hr,12hr,24hrs
• Total consumption of rescue analgesia in 1st 24 hrs
• Quality of Recovery( QoR-40) score at 24hrs
 
• Hemodynamic variables pulse rate , blood pressure (NIBP),SpO2 will be recorded before surgery and thereafter at every 15 minutes.
• VAS Score will be observed before surgery and then immediately after extubation and then at 1hr,2hr,4hr,6hr,12hr,24hrs
• Total consumption of rescue analgesia in 1st 24 hrs
• Quality of Recovery( QoR-40) score at 24hrs
 
 
Secondary Outcome  
Outcome  TimePoints 
Total consumption of rescue analgesia in 1st 24 hrs
• Quality of Recovery( QoR-40) score at 24hrs
 
24hrs  
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   19/12/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

INTRODUCTION

 

 

Breast cancer is the most common malignancy in women; surgery is one of the mainstays of treatment of breast cancer, and modified radical mastectomy is one of the standard treatments.[1–3] Postoperative pain can seriously reduce the quality of life in patients, and acute pain can even trigger chronic pain syndrome. Thoracic paravertebral, thoracic epidural, intercostal nerve, and interscalene brachial plexus blocks have been used for anesthesia and analgesia during modified radical mastectomy, but their applications are limited by the complicated nature of the procedures and severe complications.[1–4] 

In recent years, there has been increasing interest on a novel, less invasive nerve block, the pectoral nerve (PECS) block. PECS I block is an interfascial plane block administered between the pectoralis major and the pectoralis minor muscles.  The Pecs I block is a single injection of local anaesthetic between pectoralis major and pectoralis minor muscles at the level of the 3rd rib to anaesthetise the lateral and medial pectoral nerves (LPN and MPN). Indications include surgery limited to pectoralis major e.g. unilateral surgery such as insertion of breast expanders and submuscular prostheses, portacaths and implantable cardiac defibrillators/pacemakers, anterior thoracotomies and shoulder surgery involving the deltopectoral groove.The PECS II block includes the PECS I block combined with a block administered above the serratus anterior muscle at the third rib.[5,6]The Pecs II block is a modified Pecs I block and can be achieved with one needle insertion point.Local anaesthetic is placed between pectorals major and minor as in Pecs I block and then between pectoralis minor and serratus anterior muscles. This results in local anaesthetic spread under the ligament of Gerdy. The ligament of Gerdy is a thick fascia that gives the concave shape to the axilla. On its medial side it attaches to the lateral side of the pectoral muscle. This second injection will anaesthetise the anteriocutaneous branches of the intercostal nerves, the intercostobrachialis and the long thoracic nerves. Indications are similar to Pecs I with some additions: tumour resections, mastectomies, sentinel node biopsies.The Pecs II block (which also includes the Pecs I block) is an extension that involves a second injection lateral to the Pecs I injection point in the plane between the pectoralis minor and serratus anterior muscles with the intention of providing blockade of the upper intercostal nerves.

Kamiya Yet al observed the ability of PECS block to decrease postoperative pain and anaesthesia and analgesia requirements and to improve postoperative Quality of  Recovery( QoR) in patients undergoing breast cancer surgery.[7]

Erector spinae plane (ESP) block is one of the newer interfascial techniques with potential applications.  ESP block is an interfascial block that can be performed by superficial or deep needle approach. In superficial needle approach technique, drug is injected between rhomboid major muscle and erector spinae muscle, whereas in the deep needle approach, drug is injected below erector spinae muscle. [8]

Gurkan Y et al observed that ultrasound guided erector spinae plane block reduces postoperative opioid consumption  following breast surgery. [9]

Numerous clinical trials have focused on the analgesic potential of the PECS block in breast augmentation surgery, small breast surgery, and breast cancer surgery, and have shown positive results. Analgesia being an important component of anesthetic plan, effective management of postoperative pain is expected to impact perioperative quality of recovery (QoR) positively. QoR-40 score has been shown to be a valid, reliable, responsive tool in variety of surgical settings and, therefore, the best instrument to measure the complex and multidimensional process of postoperative recovery. [10-12] As there are very few studies which have compared efficacy of ESP block with PECS block after modified radical mastectomy so this study is planned to compare efficacy of PECS block with Erector Spinae block for quality of recovery and post operative analgesia after modified radical mastectomy.[13,14]

 

 

 

 

 

 

 

 

 

 

 

 

 

AIM AND OBJECTIVES

AIM- The aim of study is to compare the efficacy of PECS block and ERECTOR spinae block for postoperative quality of recovery and analgesia after Modified Radical Mastectomy

OBJECTIVE

•      The primary objective of the study is to compare Quality Of Recovery Score 40

•      Secondary Objectives are to compare:

–     Total consumption of analgesia in first 24hrs in postoperative period

–     VAS score in first 24 hrs

 

 


 

MATERIAL AND METHODS

Study setting :

Department of Anaesthesiology, King Georges Medical University, Lucknow.

Study duration : One year 

Study design: Randomized control double blind study

After getting approval from institutional ethical committee, this prospective study would be carried out in department of  Anaesthesiology, King George’s Medical University, Lucknow.

Sample size: 90 cases included in the study.

Sample size is calculated on the basis of variation in QoR-40 in the study group using the formula :

Where s = 4.1, The half IQR of QoR-40 in one of the study groups

d = 0.2 times median QoR-40  (=162.5), the minimum mean difference consider to be clinically significant.

(Ref. Mathew et. al.)[15]

type I error α = 5% corresponding to 95% confidence level

type II error β = 10% for detecting results with 90% power of study

Loss to follow up = 10%

So the required minimum sample size

n = 28(each group)

 

 

Inclusion Criteria :

â–ª         Age 18-70 years

â–ª         ASA grade 1 and  2

â–ª         Patient giving written informed consent

â–ª         Female

â–ª         unilateral modified radical mastectomy for breast cancer

 

Exclusion criteria:

●      Endocrine disorders (including I and II type of Diabetes mellitus),

●      Allergies to local anesthetics

 


 

Study procedure:

 Patients will be randomly allocated to one of the following three groups using computer generated random numbers.

Group-I  - PECS block 20 ml 0.25% bupivacaine

Group-II  - Erecter spinae block 20 ml 0.25% bupivacaine

Group III- Control Group

Patient will be clinically examined in detail and all patients will undergo investigations like Complete haemogram, Blood sugar level, Renal function test, Liver function test and Electrocardiogram. After taking  the patient  in operation theatre monitors will be attached .Patient will be monitored for heart rate, SpO2, ECG. After thatIntravenous line will be taken and an intravenous fluid  will be  started and continued throughout the procedure. . Preoxygenation will be done for 3 mins and after that patient will be induced with injection fentanyl 1ug/kg, injection propofol 2mg /kg and after confirming adequate bag and mask ventilation injection vecuronium 0.1mg/kg will be given.Then after three minutes either  second generation supraglottic airway device or endotracheal tube will be inserted. After confirmation of adequate ventilation by auscultation and capnography patient will be put on volume controlled ventilation  mode. After that patient will receive respective block according to randomization in computer generated random number table.

Group I  will receive PECS block 

Group II will receive ESP block

GROUP III will be control group 

This study  will be double blinded as patient will not be aware of  intervention which they have received as well as  the observer who will observe the patient and collect data will not be aware of what intervention each patient has received.

Postoperative analgesia – PCM 1gm IV QID

Rescue analgesic – Inj. Tramadol 100mg IV (1-2mg/kg) .

The following parameters will be  studied

·        Hemodynamic variables pulse rate , blood pressure (NIBP),SpO2 will be recorded before surgery and thereafter at every 15 minutes.

·        VAS Score will be observed before surgery and then immediately after extubation and then at  1hr,2hr,4hr,6hr,12hr,24hrs

·        Total consumption of rescue analgesia in 1st 24 hrs

·        Quality of Recovery( QoR-40)  score at 24hrs

 

 

 


 

REVIEW OF LITERATURE

 Myles PS et al (2000) observed that Quality of recovery after anaesthesia is an important measure of the early postoperative health status of patients. They attempted to develop a valid, reliable and responsive measure of quality of recovery after anaesthesia and surgery. They studied 160 patients and asked them to rate postoperative recovery using three methods: a 100-mm visual analogue scale (VAS), a nine-item questionnaire and a 50-item questionnaire; the questionnaires were repeated later on the same day. From these results, we developed a 40-item questionnaire as a measure of quality of recovery (QoR-40; maximum score 200). They found good convergent validity between QoR-40 and VAS (r = 0.68, P < 0.001). Construct validity was supported by a negative correlation with duration of hospital stay (rho = -0.24, P < 0.001) and a lower mean QoR-40 score in women (162 (SD 26)) compared with men (173 (17)) (P = 0.002). There was also good test-retest reliability (intra-class ri = 0.92, P < 0.001), internal consistency (Cronbach’s alpha = 0.93, P < 0.001) and split-half coefficient (alpha = 0.83, P < 0.001). The standardized response mean, a measure of responsiveness, was 0.65. The QoR-40 was completed in less than 6.3 (4.9) min.It was believed that the QoR-40 is a good objective measure of quality of recovery after anaesthesia and surgery. It would be a useful end-point in perioperative clinical studies.

Gurkan et al (2018) did a  Randomized controlled, single-blinded trial to evaluate the analgesic effect of ultrasound-guided erector spinae plane (ESP) block in breast cancer surgery .Fifty ASA I–II patients aged 25–65 and scheduled for elective breast cancer surgery were included in the study.Patients were randomized into two groups, ESP and control. Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level was performed preoperatively to all patients in the ESP group. The control group received no intervention. Patients in both groups were provided with intravenous patient controlled analgesia device containing morphine for post operative analgesia.Morphine consumption and numeric rating scale (NRS) pain scores were recorded at 1, 6, 12 and 24 hrs post operatively.Morphine consumption at postoperative hours 1, 6, 12 and 24 decreased significantly in the ESP group (p < 0.05 for each time interval). Total morphine consumption decreased by 65% at 24 h compared to the control group (5.76 ± 3.8 mg vs 16.6 ± 6.92 mg). There was no statistically significant difference between the groups in terms of NRS scores. Findings show that US-guided ESP block exhibits a significant analgesic effect in patients undergoing breast cancer surgery.

Kamiya Yet al (2018) conducted a study to evaluate the ability of PECS block to decrease postoperative pain and anaesthesia and analgesia requirements and to improve postoperative QoR in patients undergoing breast cancer surgery. Randomised controlled study. A tertiary hospital. Sixty women undergoing breast cancer surgery between April 2014 and February 2015. The patients were randomised to receive a PECS block consisting of 30 ml of levobupivacaine 0.25% after induction of anaesthesia (PECS group) or a saline mock block (control group). The patients answered a 40-item QoR questionnaire (QoR-40) before and 1 day after breast cancer surgery. Numeric Rating Scale score for postoperative pain, requirement for intra-operative propofol and remifentanil, and QoR-40 score on postoperative day 1. PECS block combined with propofol-remifentanil anaesthesia significantly improved the median [interquartile range] pain score at 6 h postoperatively (PECS group 1 [0 to 2] vs. Control group 1 [0.25 to 2.75]; P = 0.018]. PECS block also reduced propofol mean (± SD) estimated target blood concentration to maintain bispectral index (BIS) between 40 and 50 (PECS group 2.65 (± 0.52) vs. Control group 3.08 (± 0.41) μg ml; P < 0.001) but not remifentanil consumption (PECS group 10.5 (± 4.28) vs. Control group 10.4 (± 4.68) μg kg h; P = 0.95). PECS block did not improve the QoR-40 score on postoperative day 1 (PECS group 182 [176 to 189] vs. Control group 174.5 [157.75 to 175]). In patients undergoing breast cancer surgery, PECS block combined with general anaesthesia reduced the requirement for propofol but not that for remifentanil, due to the inability of the PECS block to reach the internal mammary area. Further, PECS block improved postoperative pain but not the postoperative QoR-40 score due to the factors that cannot be measured by analgesia immediately after surgery, such as rebound pain.

Sinha et al (2019) conducted a study Sixty four American Society of Anesthesiologists’ status I and II female patients between age 18 to 60 years scheduled for unilateral modified radical mastectomy (MRM) under general anaesthesia, were enrolled in this prospective randomised study. Patients in group I received ultrasound guided (USG) ESP block (20 cc 0.2% ropivacaine) while group II received USG guided PECS II block (25 cc 0.2% ropivacaine). General anaesthesia was administered in a standardised manner to both the groups. The various parameters observed included sensory blockade, duration of analgesia and any adverse effects. The primary outcome was the total morphine consumption in 24 hours.  The total morphine consumption in 24 hours was less in group II (4.40 ± 0.94 mg), compared to group I (6.59 ± 1.35 mg; P = 0.000). The mean duration of analgesia in patients of group II was 7.26 ± 0.69 hours while that in the group I was 5.87 ± 1. 47 hours (P value = 0.001). 26 patients in group II (PECS) had blockade of T2 as compared to only 10 patients in group I. (P value = 0.00). There was no incidence of adverse effects in either group.  PECS II block is a more effective block when compared to ESP block in patients of MRM in terms of postoperative analgesia and opioid consumption.

Altıparmak B et al (2019) conducted a study that Single-blinded, prospective, randomized, efficacy study.Tertiary university hospital, postoperative recovery room and surgical ward.Forty patients (ASA I-II) were allocated to two groups. After exclusion, 38 patients were included in the final analysis (18 patients in the PECS groups and 20 in the ESP group).Modified pectoral nerve block was performed in the PECS group and erector spinae plane block was performed in the ESP group.Postoperative tramadol consumption and pain scores were compared between the groups. Also, intraoperative fentanyl need was measured.Postoperative tramadol consumption was 132.78±22.44mg in PECS group and 196±27.03mg in ESP group (p=0.001). NRS scores at the 15th and 30thmin were similar between the groups. However, median NRS scores were significantly lower in PECS group at the postoperative 60thmin, 120thmin, 12thhour and 24th hour (p = 0.024, p=0.018, p=0.021 and p=0.011 respectively). Intraoperative fentanyl need was 75 mg in PECS group and 87.5mg in ESP group. The difference was not statistically significant (p=0.263).Modified PECS block reduced postoperative tramadol consumption and pain scores more effectively than ESP block after radical mastectomy surgery.

 

 


 

References

1.      Organization, W.H., Global Health Estimates. 2008. 

2.      Dai X, Li T, Bai Z, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res 2015;5:2929–43. 

3.      Arsalani-Zadeh R, Elfadl D, Yassin N, et al. Evidence-based review of enhancing postoperative recovery after breast surgery. Br J Surg 2011;98:181–96.

4.      Dualé C, Gayraud G, Taheri H, Bastien OSchoeffler P. A French nationwide survey on anesthesiologist-perceived barriers to the use of epidural and paravertebral block in thoracic surgery. J Cardiothorac Vasc Anesth2014;S1053077014005448.

5.      Blanco R. The ‘pecs block’: a novel technique for providing analgesia after breast surgery. Anaesthesia2011;66:847–8.

6.      Blanco R, Fajardo M, Parras MT. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim 2012;59:470–5.

7.      Kamiya Y, Hasegawa M, Yoshida T, et al. Impact of pectoral nerve block on postoperative pain and quality of recovery in patients undergoing breast cancer surgery: A randomised controlled trial. Eur J Anaesthesiol2017;35:1.

8.      Forero M, Adhikary SD, Lopez H, Tsul C, Chin KJ. The erector spinae plane block: A novel analgesic technique in thoracic neuropathic pain. Reg Anaesth Pain Med 2016;41:621-7.

9.      Gürkan Y, Aksu C, KuÅŸ A, YörükoÄŸlu UH, Kılıç CT. Ultrasound guided erector spinae plane block reduces postoperative opioid consumption following breast surgery: a randomized controlled study. J Clin Anesth. 2018;50:65–8..

10. Myles PS, Weitkamb B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: The QoR-40. Br J Anaesth 2000;84:11-5

11. Myles PS, Hunt JO, Fletcher H, Solly R. Relation between quality of recovery in hospital and quality of life at 3 months after cardiac surgery. Anesthesiology 2001;95:862-7.  

12. Leslie K, Troedel S, Irwin K, Pearce F, Ugoni A. Quality of recovery from anesthesia in neurosurgical patients. Anesthesiology 2003;99:1158-65.

13. Sinha C, Kumar A, Kumar A, Prasad C, Singh PK, Priya D. Pectoral nerve versus erector spinae block for breast surgeries: A randomised controlled trial. Indian J Anaesth 2019;63:617-22

14. Altıparmak B, Korkmaz Toker M, Uysal Aİ, Turan M, Gümüş Demirbilek S Comparison of the effects of modified pectoral nerve block and erector spinae plane block on postoperative opioid consumption and pain scores of patients after radical mastectomy surgery: A prospective, randomized, controlled trial. J Clin Anesth. 2019 May;54:61-65.

15.                      Mathew P, Aggarwal N, Kumari K, Gupta A, Panda N, Bagga R. Quality of recovery and analgesia after total abdominal hysterectomy under general anesthesia: A randomized controlled trial of TAP block vs epidural analgesia vs parenteral medications. J Anaesthesiol Clin Pharmacol 2019;35:170-5

 
Close